Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 23
Shorter regimen in sarcoma care could widen access to treatment
By
Matthew Limb
Hypofractionated, preoperative radiotherapy for patients with nonmetastatic soft tissue sarcoma can be delivered safely over three weeks and may become a "more convenient option" than conventional five-week treatment, researchers say.
November 7, 2022
Telix highlights kidney cancer imaging study results
By
AuntMinnie.com staff writers
Telix Pharmaceuticals is highlighting positive clinical results from a study that has tested its investigational kidney cancer PET imaging agent, TLX250-CDx.
November 6, 2022
Guerbet, Merative shift terms of collaboration
By
AuntMinnie.com staff writers
Contrast agent developer Guerbet and partner Merative have shifted the terms of their collaboration.
November 3, 2022
MIM Software secures Health Canada clearance for AI software
By
AuntMinnie.com staff writers
MIM Software has secured clearance from Health Canada for its artificial intelligence (AI) autocontouring software, Contour ProtégéAI.
October 31, 2022
Accuray applies for Tomo C Chinese market clearance
By
AuntMinnie.com staff writers
Radiation therapy developer Accuray has applied to the Chinese National Medical Products Administration for market clearance for its Tomo C radiation therapy system.
October 31, 2022
PET/CT bests ultrasound for imaging malignant melanoma
By
Will Morton
F-18 FDG-PET/CT imaging is a better choice than ultrasound for detecting both lymph node and abdominal metastases in patients with malignant melanoma, Swiss investigators have found.
October 31, 2022
SpectronRx names new COO
By
AuntMinnie.com staff writers
Contract development and manufacturing organization SpectronRx has appointed Peter Webner as its new chief operating officer (COO).
October 30, 2022
ASTRO: Shorter irradiation effective for breast cancer treatment
By
Amerigo Allegretto
A three-week radiation therapy course is as safe and effective as conventional treatment for early-stage breast cancer patients at higher risk of tumor recurrence, results presented at the American Society for Radiology Oncology (ASTRO) meeting show.
October 25, 2022
ASTRO: Therapy combo may slow growth of prostate cancer
By
Will Morton
Prostate cancer patients who receive radiation in addition to intermittent hormone therapy may live longer without their disease progressing, according to a talk at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.
October 25, 2022
First patient dosed with CD8 ImmunoPET in ImaginAb clinical trial
By
AuntMinnie.com staff writers
The first patient has been dosed in a clinical trial assessing immuno-PET developer ImaginAb's PET/CT imaging agent CD8 ImmunoPET.
October 24, 2022
ASTRO: Radiation therapy boosts survival rate from liver cancer
By
Kate Madden Yee
Combining radiation therapy and chemotherapy to treat patients with advanced liver cancer lengthens overall survival, according to research presented on October 24 at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.
October 24, 2022
IBA expands use of myQA iON software to radiation therapy
By
AuntMinnie.com staff writers
At the American Society for Radiation Oncology annual meeting in San Antonio, proton therapy developer Ion Beam Application (IBA) is highlighting expanded use of its myQA iON software to include linac-based radiotherapy.
October 23, 2022
Previous Page
Page 23 of 468
Next Page